Archives for May 2012

May is Mental Health Month 2012

More than 50 years ago, Mental Health America started the tradition of celebrating “May is Mental Health Month” to raise awareness of mental health conditions and mental wellness for all. For 2012, Mental Health America is addressing mental health conditions and mental wellness through two themes.

Mental health month

New Imaging Technique Allows Study of Human Heart Conduction Fibers

The human heart has a simple function: it’s a pump that circulates fluid (blood) through a series of pipes (blood vessels). However, the mechanics behind this function are quite complex. They involve an intricate series of conducting pathways that allow for the generation of an electrical impulse that propagates in a specific way through the heart muscle in order to produce a synchronized and efficient contraction, or heartbeat. While scientists understand the theory behind the electrical impulses that control the heartbeat, the specifics of the conducting pathway have been difficult to study…until now.

Heart tissue fibers

Nutrition Bar Improves Metabolic Biomarkers Linked to Cardiovascular Disease, Cognitive Decline and Anti-Oxidant Defenses

Scientists at the Children’s Hospital Oakland Research Institute (CHORI) Nutrition & Metabolism Center recently announced that they have developed a low-calorie, high-fiber, fruit-based vitamin and mineral nutrition bar called the CHORI-bar, which improves biomarkers linked to risk of cardiovascular disease, cognitive decline, and associated decline in antioxidant defenses.

Children’s Hospital Oakland Research Institute

NIH Launches Collaborative Program, Matches Researchers with Compounds to Explore New Treatments

The National Institutes of Health recently unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative’s pilot phase.

NIH collaborative program

Complete Genomics: Top Innovative Company in Biomedicine

Complete Genomics is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].

Complete Genomics